Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC). [electronic resource]
Producer: 20210412Description: 40-46 p. digitalISSN:- 1872-8332
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Large Cell -- drug therapy
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Female
- Follow-Up Studies
- Humans
- Immune Checkpoint Inhibitors -- therapeutic use
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neuroendocrine Tumors -- drug therapy
- Prognosis
- Retrospective Studies
- Small Cell Lung Carcinoma -- drug therapy
- Survival Rate
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.